Plenaries discuss AI and next-generation modality development at AAPS National Biotechnology Conference
AAPS is excited to announce the opening and closing plenary speakers for the 2024 National Biotechnology Conference (NBC), taking place May 13-16 in San Francisco, CA.
Hari Pujar, PhD, MBA, Chief Operating Officer of Tessera Therapeutics and Operating Partner at Flagship Pioneering (both MA, USA), will deliver the opening plenary on May 13 at 3 p.m. [PDT] on next-generation approaches to biotechnology modality development.
Dr Pujar is a global Pharmaceutical Executive with over 20 years of leadership experience in biologics. He has experience in manufacturing, R&D, commercialization and gene therapies, having worked for both large pharma and small biotech firms.
Peter Lee, PhD, Corporate Vice President of Research and Incubations at Microsoft (WA, USA), will discuss AI and its impact on health and life sciences in the closing plenary on May 16 at 3:15 p.m. [PDT]. In his role at Microsoft, Peter leads a team responsible for developing research-driven products that integrate new technologies such as AI with healthcare solutions.
“I can’t wait to be motivated and inspired by the opening and closing plenaries”, AAPS 2024 NBC Scientific Programming Committee Chair Katie Maass, PhD, said. “There are opportunities and challenges as we venture into new modalities and broader applications of AI, and I hope you’ll join me in hearing the perspectives of these thought leaders in the field.”
“Both Dr Pujar and Dr Lee are leaders directing new frontiers in biotechnology,” 2024 AAPS President Gopi Shankar, PhD, MBA, FAAPS, said. “I’m looking forward to hearing their insights and learning how to put them into practice. If you’re in biotechnology, I recommend the NBC and hearing from these paradigm-bending experts.”
The two plenaries bookend a scientific program that follows two tracks: ‘Advances in Discovery, Formulation, and Delivery of New Modalities’ and ‘Novel Strategies to Advance Biotherapeutic Development’.
To register for the NBC, click here.
About AAPS
American Association of Pharmaceutical Scientists (AAPS) is a non-profit association of more than 7000 scientists and professionals employed in academia, industry, regulatory and other research related to the pharmaceutical sciences worldwide. Its mission is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health, which members pursue through four peer-reviewed journals and a variety of events in person and online.
The AAPS National Biotechnology Conference (NBC) uncovers the latest science and trends that impact today’s research and pharmaceutical markets, specifically in the areas of biologics, biotechnology products and advanced therapies.
